FDA Inspection 897079 — Biomat USA, Inc

Biomat USA, Inc — FEI 1718633

The FDA completed an inspection of Biomat USA, Inc on Sep 24, 2014 in Savannah, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Sep 24, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Savannah, GA (United States)